At the halfway point of 2019, investors were met with major changes in the cannabis industry.

The marijuana market has faced challenges this past month as two established companies underwent transition periods, including a chaotic discovery and the end of an era for an industry leader.

During the month of July, cannabis investors were tested as storming developments from cannabis producers CannTrust Holdings (NYSE:CTST,TSX:TRST) and Canopy Growth (NYSE:CGC,TSX:WEED) affected the performance of the sector.

CannTrust faces scandal

Canadian cannabis producer CannTrust Holdings suffered a massive drop off after it was revealed the firm had hosted illicit growing operations in unlicensed rooms at its Pelham, Ontario facility.

Thanks to the actions of a whistleblower — former CannTrust employee Nick Lalonde — Health Canada, the regulatory agency tasked with overseeing licenses, confirmed the improper growing. CannTrust was forced to place a hold on its product, although reports then showed provincial and international partners had already received the unlicensed product.

Besides the initial chaos from the scandal, which led the shares of the company to plummet, the market soured further on CannTrust after a Globe and Mail report found internal emails showing high-ranking executives were aware of the unlicensed growing rooms.

After completing an internal review, a special committee fired CEO Peter Aceto and asked Paul Trust, co-founder, former CEO and active chairman of the board, to resign from the firm.

CannTrust ended the month by announcing it has secured the services of Greenhill & Co. Canada as a financial advisor to determine strategic alternatives for the company and its assets.

Canopy Growth fires co-founder and CEO

Canopy Growth, one of the leading marijuana companies, announced the dismissal of Bruce Linton as co-CEO of the company in July.

Linton has become a dominant voice on the direction of the marijuana industry. In his time at the company, he oversaw Canopy Growth’s rise to become a global company with a New York Stock Exchange listing and a valuation of over C$15 billion. Fellow Co-CEO Mark Zekulin has taken over full responsibilities at the helm of the company while its board of directors moves forward with a search for the next leading executive.

“I personally remain committed to a successful transition over the coming year as we begin a process to identify new leadership that will drive our collective vision forward,” Zekulin said in a statement.

Linton came under heavy scrutiny after dismal losses from his company as part of its most recent quarter and fiscal year. During a conference call with investors, Bill Newlands, CEO of alcohol maker and Canopy Growth investor Constellation Brands (NYSE:STZ), acknowledged that his company wasn’t too enthused with the recent financials from the marijuana firm.

“While we remain happy with our investment in the cannabis space and its long-term potential, we were not pleased with Canopy’s recent reported year-end results,” Newlands said.

Watch the video above for more on what happened in cannabis during the month of July.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less